Sanofi-Aventis U.S. is being sued by consumers of Ketek – an antibiotic used to treat sinusitis, bronchitis and pneumonia – from 47 applicants from all over the country in St. Clair County Circuit CourtRepresented by Christopher Cueto of Belleville and John J. Driscoll of Brown & Crouppen in St. Louis, the complaint submitted November 15 should damages for personal injuries and economic. The plaintiffs argue that Sanofi-Aventis USA, a subsidiary of French pharmaceutical, knew there was an increased risk of Ketek consumers suffer injury or death from liver failure and hepatics injuries.
The complaint alleges that Ketek is an erroneous and dangerous drugs.
Four of the 47 plaintiffs live in Illinois. Among those are local, Dorothy Ray lives in Swansea and Cynthia Hamilton is located in Alton.
Other applicants are from North Carolina, South Carolina, Tennessee, Indiana, Arizona, Florida, New York, Pennsylvania, Kansas, Missouri, West Virginia, Utah, Maine, Delaware, Iowa, Texas, Arkansas, Virginia, Georgia, Mississippi and New Jersey .
Among other things, plaintiffs claim that the defendant against the New Jersey Consumer Fraud Act (NJCFA).
“In violation of the NJCFA, defendant, the deception, fraud, false pretense, false promise, false statements or knowing concealment, suppression or omission of material facts in relation to the risks of injury associated with the use of Ketek .. ., “The complaint states.
The complaint alleges that Sanofi-Aventis intentionally concealed by the Food and Drug Administration (FDA) the results of a study which showed serious damage in connection with the use of Ketek.